Those of us with rare conditions like IgG4-related disease often talk about the struggle to access affordable and equitable healthcare, but what happens after we temporarily overcome those hurdles? I say “temporarily” because, as many of us know, the obstacles never truly end. We’re constantly forced to jump through…
Azathioprine, an immunosuppressive medication, may help keep immunoglobulin G4-related disease (IgG4-RD) under control over the long term, while reducing glucocorticoid, or steroid, use, according to a small real-world study in Austria. In most of the 10 patients evaluated, azathioprine — primarily used to treat immune diseases — was…
Closely monitoring disease activity without starting medication immediately — an approach called watchful waiting — may raise the risk of relapse for people with mild IgG4-related disease (IgG4-RD), according to a real-world study from China. In people with IgG4-RD, watchful waiting is sometimes used as a strategy for patients…
Get regular updates to your inbox.
